The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species

Biomaterials

Volumn 31, Issue 24, 2010, Pages 6142-6153

  Huang, Xinglu ^a,d   Zhuang, Jie ^b,d   Teng, Xu ^c   Li, Linlin ^a   Chen, Dong ^a   Yan, Xiyun ^b   Tang, Fangqiong ^a  

^a TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Mesoporous silica nanoparticles; Molecular mechanism; Promotion tumor growth; Reactive oxygen species

Indexed keywords

APOPTOTIC; CELL-CYCLE PROGRESSION; CELLULAR UPTAKE; DRUG DELIVERY CARRIER; DRUG DELIVERY SYSTEM; IN-CELL; IN-VITRO; IN-VIVO; MALIGNANT MELANOMA; MESOPOROUS SILICA NANOPARTICLES; MOLECULAR BEHAVIOR; MOLECULAR MECHANISM; NANOCARRIERS; NUDE MICE; PROMOTION EFFECTS; REACTIVE OXYGEN SPECIES; SENSITIVE SIGNALS; TUMOR GROWTH; TUMOR THERAPY; UP-REGULATION;

CELL PROLIFERATION; DERMATOLOGY; DRUG DELIVERY; MOLECULAR OXYGEN; NANOPARTICLES; ONCOLOGY; SILICA;

TUMORS;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESOPOROUS SILICA NANOPARTICLES; NANOCARRIER; NANOPARTICLE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; GLUTATHIONE; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; DRUG DELIVERY SYSTEM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MELANOMA CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NUDE MOUSE; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CELL CYCLE; CONTRAINDICATIONS; DRUG EFFECTS; DRUG SCREENING; ENDOCYTOSIS; INTRACELLULAR SPACE; MELANOMA; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOCYTOSIS; GLUTATHIONE; HUMANS; INTRACELLULAR SPACE; MELANOMA; MICE; NANOPARTICLES; NF-KAPPA B; OXIDATION-REDUCTION; POROSITY; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SILICON DIOXIDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 77953649363     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.055     Document Type: Article

References (38)

1. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 6(8):1794-1807.
2. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3(2):279-290.
3. Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., et al. Gold nanoparticles of diameter 1.4nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5(18):2067-2076.
4. Zhang L., Laug L., Munchgesang W., Pippel E., Gosele U., Brandsch M., et al. Reducing stress on cells with apoferritin-encapsulated platinum nanoparticles. Nano Lett 2010, 10(1):219-223.
5. Huang D.M., Hsiao J.K., Chen Y.C., Chien L.Y., Yao M., Chen Y.K., et al. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 2009, 30(22):3645-3651.
6. Park J.H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 2009, 8(4):331-336.
7. Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008, 60(11):1278-1288.
8. Slowing I.I., Trewyn B.G., Lin V.S. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007, 129(28):8845-8849.
9. Kim J., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl 2008, 47(44):8438-8441.
10. Slowing I., Trewyn B.G., Lin V.S. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 2006, 128(46):14792-14793.
11. Qian J., Gharibi A., He S. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy. J Biomed Opt 2009, 14(1):014012.
12. Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3(8):1341-1346.
13. Li Y., Rory Goodwin C., Sang Y., Rosen E.M., Laterra J., Xia S. Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms. Anticancer Drugs 2009, 20(9):770-778.
14. Lin X., Li Q., Wang Y.J., Ju Y.W., Chi Z.Q., Wang M.W., et al. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J 2007, 406(2):215-221.
15. Yang J., Li H., Chen Y.Y., Wang X.J., Shi G.Y., Hu Q.S., et al. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radic Biol Med 2004, 37(12):2027-2041.
16. Jang J.H., Surh Y.J. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem Pharmacol 2003, 66(8):1371-1379.
17. Huang X., Teng X., Chen D., Tang F., He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 2010, 31(3):438-448.
18. Abu Lila A.S., Kizuki S., Doi Y., Suzuki T., Ishida T., Kiwada H. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Release 2009, 137(1):8-14.
19. Faklaris O., Joshi V., Irinopoulou T., Tauc P., Sennour M., Girard H., et al. Photoluminescent diamond nanoparticles for cell labeling: study of the uptake mechanism in mammalian cells. ACS Nano 2009, 3(12):3955-3962.
20. Foucaud L., Wilson M.R., Brown D.M., Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol Lett 2007, 174(1-3):1-9.
21. He Z., Sun X., Mei G., Yu S., Li N. Nonclassical secretion of human catalase on the surface of CHO cells is more efficient than classical secretion. Cell Biol Int 2008, 32(4):367-373.
22. Zhu M.T., Feng W.Y., Wang B., Wang T.C., Gu Y.Q., Wang M., et al. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology 2008, 247(2-3):102-111.
23. Kuo J.H., Jan M.S., Lin Y.L. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers. J Control Release 2007, 120(1-2):51-59.
24. Brown D.I., Griendling K.K. Nox proteins in signal transduction. Free Radic Biol Med 2009, 47(9):1239-1253.
25. Miao L., St Clair D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009, 47(4):344-356.
26. Baeuerle P.A. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 1998, 95(6):729-731.
27. Qi L., Xu Z., Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 2007, 43(1):184-193.
28. Zogovic N.S., Nikolic N.S., Vranjes-Djuric S.D., Harhaji L.M., Vucicevic L.M., Janjetovic K.D., et al. Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60). Biomaterials 2009, 30(36):6940-6946.
29. Huang D.M., Hung Y., Ko B.S., Hsu S.C., Chen W.H., Chien C.L., et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J 2005, 19(14):2014-2016.
30. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995, 92(16):7297-7301.
31. Leborgne-Castel N., Lherminier J., Der C., Fromentin J., Houot V., Simon-Plas F. The plant defense elicitor cryptogein stimulates clathrin-mediated endocytosis correlated with reactive oxygen species production in bright yellow-2 tobacco cells. Plant Physiol 2008, 146(3):1255-1266.
32. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991, 51(3):794-798.
33. Mossman B.T. Introduction to serial reviews on the role of reactive oxygen and nitrogen species (ROS/RNS) in lung injury and diseases. Free Radic Biol Med 2003, 34(9):1115-1116.
34. Fenoglio I., Tomatis M., Lison D., Muller J., Fonseca A., Nagy J.B., et al. Reactivity of carbon nanotubes: free radical generation or scavenging activity?. Free Radic Biol Med 2006, 40(7):1227-1233.
35. Autret A., Martin S.J. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 2009, 36(3):355-363.
36. Naoi M., Maruyama W., Yi H., Inaba K., Akao Y., Shamoto-Nagai M. Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J Neural Transm 2009, 116(11):1371-1381.
37. Fan Y., Dutta J., Gupta N., Fan G., Gelinas C. Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy. Adv Exp Med Biol 2008, 615:223-250.
38. Manna S.K., Sarkar S., Barr J., Wise K., Barrera E.V., Jejelowo O., et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett 2005, 5(9):1676-1684.